CIK: 0001493215 · Show all filings
Period: Q3 2016 (← Previous) (Next →)
Filing Date: Nov 18, 2016
Total Value ($000): $330,886 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ALNY | Alnylam Pharmaceuticals Inc | 948,286 | $64,275 | 19.4% | $86.12 | -18.1% | COM | 02043Q107 |
| — | Avexis Inc | 825,980 | $34,039 | 10.3% | $33.15 | — | COM | 05366U100 |
| — | Agenus Inc | 4,141,644 | $29,737 | 9.0% | $7.65 | — | COM NEW | 00847G705 |
| — | La Jolla Pharmaceutical Co | 1,170,151 | $27,838 | 8.4% | $25.02 | — | COM PAR $.0001 2 | 503459604 |
| BCRX | BioCryst Pharmaceuticals Inc | 4,204,579 | $18,542 | 5.6% | $7.25 | -44.9% | COM | 09058V103 |
| INCY | Incyte Corp | 191,151 | $18,024 | 5.4% | $74.63 | +12.9% | COM | 45337C102 |
| — | Achillion Pharmaceuticals Inc | 2,208,749 | $17,891 | 5.4% | $10.21 | — | COM | 00448Q201 |
| — | Dicerna Pharmaceuticals Inc | 2,026,894 | $11,918 | 3.6% | $13.12 | — | COM | 253031108 |
| BMY | Bristol-Myers Squibb Co | 209,701 | $11,307 | 3.4% | $48.14 | -4.1% | COM | 110122108 |
| GLD | SPDR Gold Trust | 83,000 | $10,428 | 3.2% | $126.47 | — | GOLD SHS | 78463V107 |
| — | Atara Biotherapeutics Inc. | 458,113 | $9,799 | 3.0% | $21.39 | — | COM | 46513107 |
| ARWR | Arrowhead Pharmaceuticals Inc | 1,116,777 | $8,208 | 2.5% | $6.48 | 0.0% | COM | 04280A100 |
| HRTX | Heron Therapeutics Inc | 386,787 | $6,664 | 2.0% | $18.55 | 0.0% | COM | 427746102 |
| — | Viveve Medical Inc | 839,274 | $6,060 | 1.8% | $4.19 | — | COM NEW | 92852W204 |
| — | bluebird bio Inc | 87,734 | $5,947 | 1.8% | $43.60 | — | COM | 09609G100 |
| — | Corium International Inc | 1,045,747 | $5,888 | 1.8% | $9.36 | — | COM | 21887L107 |
| — | Invuity Inc | 392,838 | $5,390 | 1.6% | $13.24 | — | COM | 46187J205 |
| — | Celldex Therapeutics Inc | 1,243,164 | $5,022 | 1.5% | $12.18 | — | COM | 15117B103 |
| — | Medicines Co | 123,000 | $4,642 | 1.4% | $37.74 | — | COM | 584688105 |
| OMER | Omeros Corp | 383,012 | $4,274 | 1.3% | $14.29 | -20.1% | COM | 682143102 |
| TCMD | Tactile Systems Technology Inc Cmn | 227,599 | $4,256 | 1.3% | $15.35 | 0.0% | COM | 87357P100 |
| — | Barclays Bank Plc | 180,500 | $4,018 | 1.2% | $22.17 | — | ETN DJUBSCOFFE38 | 06739H297 |
| RGNX | Regenxbio Inc | 238,740 | $3,345 | 1.0% | $24.07 | -54.2% | COM | 75901B107 |
| — | Oxford Immunotec Global PLC | 235,900 | $2,963 | 0.9% | $12.56 | — | ORD SHS | G6855A103 |
| — | Five Prime Therapeutics Inc | 44,044 | $2,312 | 0.7% | $22.81 | — | COM | 33830X104 |
| — | Global Blood Therapeutics Inc | 95,714 | $2,206 | 0.7% | $35.72 | — | COM | 37890U108 |
| MASI | Masimo Corp | 25,900 | $1,541 | 0.5% | $40.86 | +38.1% | COM | 574795100 |
| — | NOVAVAX INC | 4,787 | $996 | 0.3% | — | — | Call | 670002104 |
| — | Mirati Therapeutics Inc | 129,129 | $854 | 0.3% | $33.11 | — | COM | 60468T105 |
| SRTS | Sensus Healthcare Inc Cmn | 125,700 | $773 | 0.2% | $6.26 | 0.0% | COM | 81728J109 |
| — | Biopharmx Corp | 700,636 | $389 | 0.1% | $1.87 | — | COM | 09072X101 |
| — | Audentes Therapeutics Inc | 20,000 | $356 | 0.1% | $17.80 | — | COM | 05070R104 |
| NTRA | Natera Inc | 31,693 | $352 | 0.1% | $16.90 | -33.3% | COM | 632307104 |
| — | MANNKIND CORP | 4,385 | $272 | 0.1% | — | — | Put | 56400P201 |
| — | Nivalis Therapeutics Inc | 30,000 | $244 | 0.1% | $15.17 | — | COM | 65481J109 |
| — | Abeona Therapeutics Inc | 19,391 | $116 | 0.0% | $5.98 | — | COM | 00289Y107 |